Difference between revisions of "WSI21-134"
From MGH Learn Pathology
(Edited automatically from page WSI21-134.) |
(Edited automatically from page WSI21-134.) |
||
Line 332: | Line 332: | ||
|requester=Mlz8 | |requester=Mlz8 | ||
|authoredOn=May 19, 2023 19:08:00 | |authoredOn=May 19, 2023 19:08:00 | ||
+ | }} | ||
+ | {{status | ||
+ | |status=active | ||
+ | |identifier=WSI21-134 | ||
+ | |requester=Iac0 | ||
+ | |authoredOn=May 25, 2023 20:12:03 | ||
}} | }} |
Revision as of 15:12, May 25, 2023
Request details
Toggle columns: Diagnosis
Case | Clinical history | Requester | Diagnosis |
---|---|---|---|
Case | Clinical history | Requester | Diagnosis |
| 18-year-old male. History of glioblastoma. | Iac0 | Metastatic glioblastoma. |
| 80yo M with left-sided pleural effusion | Mlz8 | Metastatic small cell lung carcinoma |
| 69yo F with pleural effusion | Mlz8 | Metastatic breast carcinoma (h/o invasive lobular carcinoma) |
| 48M • kidney failure. Pleura FNA. | Iac0 | Extramedullary hematopoiesis. |
| Over 90-year old male with significant asbestos exposure | Lcm51 | Mesothelioma |
| Pericardial effusion and history of parotid mass and atrial mass | Mlz8 | Metastatic Merkel cell carcinoma (from parotid primary) |
| 33F. Peritoneal carcinomatosis. | Iac0 | SMARCB1/INI1-deficient malignant epithelioid neoplasm. |
| 45 y/old F Long Hx of ESRD post kidney transplant. New effusion • duodenal mass and peritoneal nodules. | Lcm51 | PTLD • DLBCL type. |
| 41M. History of clear cell sarcoma of finger. | Iac0 | Metastatic clear cell sarcoma. |
| 73y/old F with right pleural effusion and flank pain. | Aja51 | Dx Epithelioid mesothelioma |
| 60 y/old F with new pleural effusion and prior "soft tissue" tumor in the arm. | Aja51 | Metastatic epithelioid hemangioendothelioma |
| 79 yo male | Ndk6 | Multiple myeloma |
| 50 yo female with history of metastatic carcinoma with bilateral pleural effusions | Ndk6 | Metastatic ovarian carcinoma • clear cell type |
| 65 yo M with a history of myeloma. | Cfh13 | Positive. Recurrent multiple myeloma to pleura. |
| HISTORY OF MULTIPLE MYEOMA WITH PLASMACYTOMA. NOW HAS PLEURAL EFFUSIONS | Pab16 | Plasma cell myeloma |
| 78 YO male with h/o adenocarcinoma of pyloric antrum and ascites | Ndk6 | Metastatic adenocarcinoma c/w patient's known malignancy |
| Hx triple negative breast cancer | Est105 | Metastatic breast carcinoma |
| 18-year-old man | Eh441 | Burkitt lymphoma |
| 55 yo F with a remote history of breast carcinoma. | Cfh13 | Metastatic adenocarcinoma • consistent with breast primary. |
| 55 yo M with chronic pleural effusion. | Cfh13 | Positive for malignant cells. Epithelioid hemangioendothelioma. |
| 52 yo F with acute respiratory failure in the setting of cocci and remote myeloma. | Cfh13 | Malignant cells present • consistent with involvement by the patient's known multiple myeloma. |
| 68yo man with a history of oncocytic thyroid carcinoma (metastatic to one lymph node) and clear cell renal cell carcinoma | Ez278 | Metastatic oncocytic carcinoma • consistent with spread from thyroid primary. |
| 68 yo woman with an ovarian mass | Cfh13 | Positive for metastatic ovarian serous carcinoma in a background of mucinous borderline tumor. |
| 73 yo man with ascites noted on surveillance following a Whipple for pancreatic carcinoma | Cfh13 | Malignant mesothelioma • epithelioid type. |
| 27 yo F with unrescetable thymic carcinoma | Ndk6 | Consistent with patient's known thymic carcinoma. Immunohistochemical studies show that the malignant cells are positive for p63 and CD5 • supporting the diagnosis. |
| 80-year-old man | Njc35 | Epithelioid mesothelioma.
Fibrosis and multinucleated giant cell reaction to polarizable foreign material • consistent with talc pleurodesis. Note: Immunohistochemistry - tumor cells are positive for calretinin and WT1. They show loss of membranous/ cytoplasmic expression of merlin/NF2. They show retained expression of MTAP. |
| 49M • ascites fluid | Mlz8 | Metastatic gastric signet ring cell adenocarcinoma |
| 69F. Pleural based mass. | Iac0 | Epithelioid mesothelioma. |
| 73 yo male | Dc679 | Metastatic Ewing Sarcoma |
| 34 yo male with left empyema and c/f lymphoma | Ndk6 | High-grade B-cell lymphoma • consistent with Burkitt lymphoma |
| 75 yo male | Ndk6 | Atypical lymphoid cells present • consistent with involvement by mantle cell lymphoma |
| 72 yo female with thyroid cancer with recurrent right pleural effusion | Ndk6 | Metastatic carcinoma • consistent with the patient’s thyroid primary |
| 67F. Pelvic mass. Pelvic ascites. | Iac0 | Mucinous epithelium • consistent with involvement by ovarian mucinous neoplasm. Resection: borderline mucinous neoplasm. |
| 62F. History of papillary thyroid carcinoma. Now with pleural effusion. | Iac0 | Metastatic papillary thyroid carcinoma. |
| 20M. History of CNS lymphoma. | Iac0 | ALK-positive anaplastic large cell lymphoma (ALCL). |
| 87 YOF with with recurrent advanced pulmonary adenocarcinoma who recently developed myocarditis after Pembrolizumab and pleural effusion. | Tz046 | Metastatic adenocarcinoma. |